Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Henrik B. Jørgensen"'
Autor:
Maja Hinge, Kristian T. Andersen, Thomas Lund, Henrik B. Jørgensen, Paw C. Holdgaard, Tina E. Ormstrup, Lone L. Østergaard, Torben Plesner
Publikováno v:
Haematologica, Vol 101, Iss 10 (2016)
Externí odkaz:
https://doaj.org/article/8ec38c6ae4bc4b2bb715464d6e2acded
Autor:
Henrik B Jørgensen, Paw Christian Holdgaard, Lone Lange Østergaard, Kristian Thidemann Andersen, Tina Ormstrup, Maja Hinge, Thomas Lund, Torben Plesner
Publikováno v:
Hinge, M, Andersen, K T, Lund, T, Jørgensen, H B, Holdgaard, P C, Ormstrup, T E, Lange Østergaard, L & Plesner, T 2016, ' Bone healing in multiple myeloma : A prospective evaluation of the impact of first-line anti-myeloma treatment ', Haematologica, vol. 101, no. 10, pp. e419-e422 . https://doi.org/10.3324/haematol.2016.144477
Myeloma cells disturb a normally balanced bone remodeling process. This imbalance of bone metabolism may cause osteopenic bones, focal osteolytic lesions and clinical symptoms. The excess bone resorption resulting in osteolytic lesions has traditiona
Autor:
Erik H Jakobsen, Charlotte Toftmann Hansen, Kent Søe, Henrik B Jørgensen, Torben Plesner, Jean-Marie Delaissé
Publikováno v:
Journal of Bone and Mineral Research. 28:1738-1750
Zoledronic acid (Zol) is used to treat bone disease in both multiple myeloma (MM) and breast cancer patients with bone metastasis (BC). However, bones of MM and BC patients show a difference in retention of the bisphosphonate used for bone scintigrap
Autor:
Paw Christian Holdgaard, Tina Ormstrup, Thomas Lund, Henrik B Jørgensen, Lone Lange Østergaard, Maja Hinge, Torben Plesner, Kristian Thidemann Andersen
Publikováno v:
Hinge, M, Andersen, K T, Lund, T, Jørgensen, H B, Holdgaard, P C, Ormstrup, T E, Lange Østergaard, L & Plesner, T 2016, ' Baseline bone involvement in multiple myeloma-a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients ', Haematologica, vol. 101, no. 10, pp. e415-e418 . https://doi.org/10.3324/haematol.2016.146092
Examination of bone lesions is a compulsory part of baseline assessments in patients with multiple myeloma (MM). Low-dose computed tomography (CT) scan has recently been recommended as a replacement of conventional X-ray for the diagnosis of osteolyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7077dc9b1389f837078c1f29259a43d8
https://europepmc.org/articles/PMC5046664/
https://europepmc.org/articles/PMC5046664/
Autor:
Kent, Søe, Torben, Plesner, Erik H, Jakobsen, Charlotte T, Hansen, Henrik B, Jørgensen, Jean-Marie, Delaissé
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 28(8)
Zoledronic acid (Zol) is used to treat bone disease in both multiple myeloma (MM) and breast cancer patients with bone metastasis (BC). However, bones of MM and BC patients show a difference in retention of the bisphosphonate used for bone scintigrap
Autor:
Allan H D, Johansen, Poul Flemming, Høilund-Carlsen, Henrik B, Jørgensen, Peter H, Bartram, Annegrete, Veje, Svend, Hvidsten, Jens, Marving
Publikováno v:
Ugeskrift for laeger. 165(10)
Autor:
Maja Hinge, Kristian T Andersen, Thomas Lund, Henrik B Jørgensen, Paw C Holdgaard, Tina E Ormstrup, Lone L Østergaard, Torben Plesner
Publikováno v:
Haematologica, Vol 101, Iss 10 (2016)
Externí odkaz:
https://doaj.org/article/c802f3a9bc9d4b128e8f17d2ce78475e